162 related articles for article (PubMed ID: 38052820)
1. Deletion of Mettl3 in mesenchymal stem cells promotes acute myeloid leukemia resistance to chemotherapy.
Liao X; Cai D; Liu J; Hu H; You R; Pan Z; Chen S; Xu K; Dai W; Zhang S; Lin X; Huang H
Cell Death Dis; 2023 Dec; 14(12):796. PubMed ID: 38052820
[TBL] [Abstract][Full Text] [Related]
2. METTL3 mediates bone marrow mesenchymal stem cell adipogenesis to promote chemoresistance in acute myeloid leukaemia.
Pan ZP; Wang B; Hou DY; You RL; Wang XT; Xie WH; Huang HF
FEBS Open Bio; 2021 Jun; 11(6):1659-1672. PubMed ID: 33932138
[TBL] [Abstract][Full Text] [Related]
3. Tumor-suppressive MEG3 induces microRNA-493-5p expression to reduce arabinocytosine chemoresistance of acute myeloid leukemia cells by downregulating the METTL3/MYC axis.
Wang A; Chen Y; Shi L; Li M; Li L; Wang S; Wang C
J Transl Med; 2022 Jun; 20(1):288. PubMed ID: 35761379
[TBL] [Abstract][Full Text] [Related]
4. METTL3 mediates chemoresistance by enhancing AML homing and engraftment via ITGA4.
Li M; Ye J; Xia Y; Li M; Li G; Hu X; Su X; Wang D; Zhao X; Lu F; Li J; Ma D; Sun T; Ji C
Leukemia; 2022 Nov; 36(11):2586-2595. PubMed ID: 36266324
[TBL] [Abstract][Full Text] [Related]
5. Acute myeloid leukemia (AML)-derived mesenchymal stem cells induce chemoresistance and epithelial-mesenchymal transition-like program in AML through IL-6/JAK2/STAT3 signaling.
Lu J; Dong Q; Zhang S; Feng Y; Yang J; Zhao L
Cancer Sci; 2023 Aug; 114(8):3287-3300. PubMed ID: 37272257
[TBL] [Abstract][Full Text] [Related]
6. Critical role of Lama4 for hematopoiesis regeneration and acute myeloid leukemia progression.
Cai H; Kondo M; Sandhow L; Xiao P; Johansson AS; Sasaki T; Zawacka-Pankau J; Tryggvason K; Ungerstedt J; Walfridsson J; Ekblom M; Qian H
Blood; 2022 May; 139(20):3040-3057. PubMed ID: 34958665
[TBL] [Abstract][Full Text] [Related]
7. Bone Marrow Mesenchymal Stem Cells Support Acute Myeloid Leukemia Bioenergetics and Enhance Antioxidant Defense and Escape from Chemotherapy.
Forte D; García-Fernández M; Sánchez-Aguilera A; Stavropoulou V; Fielding C; Martín-Pérez D; López JA; Costa ASH; Tronci L; Nikitopoulou E; Barber M; Gallipoli P; Marando L; Fernández de Castillejo CL; Tzankov A; Dietmann S; Cavo M; Catani L; Curti A; Vázquez J; Frezza C; Huntly BJ; Schwaller J; Méndez-Ferrer S
Cell Metab; 2020 Nov; 32(5):829-843.e9. PubMed ID: 32966766
[TBL] [Abstract][Full Text] [Related]
8. HDAC1/3-dependent moderate liquid-liquid phase separation of YY1 promotes METTL3 expression and AML cell proliferation.
Li M; Li M; Xia Y; Li G; Su X; Wang D; Ye J; Lu F; Sun T; Ji C
Cell Death Dis; 2022 Nov; 13(11):992. PubMed ID: 36424383
[TBL] [Abstract][Full Text] [Related]
9. DNA damage to bone marrow stromal cells by antileukemia drugs induces chemoresistance in acute myeloid leukemia via paracrine FGF10-FGFR2 signaling.
Yu S; Ye J; Wang Y; Lu T; Liu Y; Liu N; Zhang J; Lu F; Ma D; Gale RP; Ji C
J Biol Chem; 2023 Jan; 299(1):102787. PubMed ID: 36509141
[TBL] [Abstract][Full Text] [Related]
10. Clonal MDS/AML cells with enhanced TWIST1 expression reprogram the differentiation of bone marrow MSCs.
Li H; Wang Y; Yang F; Feng S; Chang K; Yu X; Guan F; Li X
Redox Biol; 2023 Nov; 67():102900. PubMed ID: 37748319
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 Facilitates Acute Myeloid Leukemia Chemoresistance via Mitofusin 1-Mediated Mitochondrial Fusion.
Hou D; Zheng X; Cai D; You R; Liu J; Wang X; Liao X; Tan M; Lin L; Wang J; Zhang S; Huang H
Mol Cancer Res; 2023 Dec; 21(12):1366-1378. PubMed ID: 37698549
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a PROTAC degrader for METTL3-METTL14 complex.
Du W; Huang Y; Chen X; Deng Y; Sun Y; Yang H; Shi Q; Wu F; Liu G; Huang H; Ding J; Huang X; Xu S
Cell Chem Biol; 2024 Jan; 31(1):177-183.e17. PubMed ID: 38194973
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1β inhibits normal hematopoietic expansion and promotes acute myeloid leukemia progression via the bone marrow niche.
Wang Y; Sun X; Yuan S; Hou S; Guo T; Chu Y; Pang T; Luo HR; Yuan W; Wang X
Cytotherapy; 2020 Mar; 22(3):127-134. PubMed ID: 32024607
[TBL] [Abstract][Full Text] [Related]
14. Coculture in vitro with endothelial cells induces cytarabine resistance of acute myeloid leukemia cells in a VEGF-A/VEGFR-2 signaling-independent manner.
Okamoto S; Miyano K; Kitakaze K; Kato H; Yamauchi A; Kajikawa M; Itsumi M; Kawai C; Kuribayashi F
Biochem Biophys Res Commun; 2022 Jan; 587():78-84. PubMed ID: 34872003
[TBL] [Abstract][Full Text] [Related]
15. The N
Vu LP; Pickering BF; Cheng Y; Zaccara S; Nguyen D; Minuesa G; Chou T; Chow A; Saletore Y; MacKay M; Schulman J; Famulare C; Patel M; Klimek VM; Garrett-Bakelman FE; Melnick A; Carroll M; Mason CE; Jaffrey SR; Kharas MG
Nat Med; 2017 Nov; 23(11):1369-1376. PubMed ID: 28920958
[TBL] [Abstract][Full Text] [Related]
16. Atg5-dependent autophagy contributes to the development of acute myeloid leukemia in an MLL-AF9-driven mouse model.
Liu Q; Chen L; Atkinson JM; Claxton DF; Wang HG
Cell Death Dis; 2016 Sep; 7(9):e2361. PubMed ID: 27607576
[TBL] [Abstract][Full Text] [Related]
17. Mettl3-mediated m
Wu Y; Xie L; Wang M; Xiong Q; Guo Y; Liang Y; Li J; Sheng R; Deng P; Wang Y; Zheng R; Jiang Y; Ye L; Chen Q; Zhou X; Lin S; Yuan Q
Nat Commun; 2018 Nov; 9(1):4772. PubMed ID: 30429466
[TBL] [Abstract][Full Text] [Related]
18. Bone mesenchymal stem cell-derived exosomal microRNA-7-5p inhibits progression of acute myeloid leukemia by targeting OSBPL11.
Jiang D; Wu X; Sun X; Tan W; Dai X; Xie Y; Du A; Zhao Q
J Nanobiotechnology; 2022 Jan; 20(1):29. PubMed ID: 35012554
[TBL] [Abstract][Full Text] [Related]
19. Disruption of gap junctions attenuates acute myeloid leukemia chemoresistance induced by bone marrow mesenchymal stromal cells.
Kouzi F; Zibara K; Bourgeais J; Picou F; Gallay N; Brossaud J; Dakik H; Roux B; Hamard S; Le Nail LR; Hleihel R; Foucault A; Ravalet N; Rouleux-Bonnin F; Gouilleux F; Mazurier F; Bene MC; Akl H; Gyan E; Domenech J; El-Sabban M; Herault O
Oncogene; 2020 Feb; 39(6):1198-1212. PubMed ID: 31649334
[TBL] [Abstract][Full Text] [Related]
20. Distinct roles of mesenchymal stem and progenitor cells during the development of acute myeloid leukemia in mice.
Xiao P; Sandhow L; Heshmati Y; Kondo M; Bouderlique T; Dolinska M; Johansson AS; Sigvardsson M; Ekblom M; Walfridsson J; Qian H
Blood Adv; 2018 Jun; 2(12):1480-1494. PubMed ID: 29945938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
